For decades, the medical and life science communities have discussed boosting diversity in clinical trials. However, research today is still coming up short. According to a 2019 JAMA study, out of 230 trials leading to FDA oncology drug approvals over the past decade, race was only reported by 63%.
“We would want representation of trial participants to reflect the population of the disease that'...
It’s no secret that a person’s overall health and wellness can depend a lot more on factors outside the doctor’s office than inside it. A person’s housing, education, access to healthcare, social inequities, institutional inequities and other social determinants of health play into a person’s overall health.
Health equity challenges exist around the globe. However, the COVID-19 pandemic and ...
